Egypt vs Laos: Average non-HDL cholesterol levels

Egypt
3.3
in 2018
Laos
3.3
in 2018
Egypt rank
95th
Laos rank
95th

Average non-HDL cholesterol levels over time

  • Egypt
  • Laos
01234198019992018

How they compare

Egypt currently reports 3.3 against 3.3 in Laos, a difference of 0.

The two have swapped places 1 time across 39 shared years of data; in 1980 it was Egypt ahead.

Egypt ranks 95th and Laos ranks 95th of 191 countries.

Egypt has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Egypt Laos Difference Ahead
1980s 3.41 2.7 0.71 Egypt
1990s 3.56 2.91 0.65 Egypt
2000s 3.58 3.12 0.46 Egypt
2010s 3.41 3.28 0.1333 Egypt

Averages of every year both report within each decade.

Frequently asked questions

Which has higher average non-hdl cholesterol levels, Egypt or Laos?
Egypt, at 3.3 against 3.3 in Laos as of 2018.
What is the difference in average non-hdl cholesterol levels between Egypt and Laos?
0, with Egypt ahead.
How many years of comparable data are there for Egypt and Laos?
39 years are reported by both, from 1980 to 2018.
How do Egypt and Laos rank globally for average non-hdl cholesterol levels?
Egypt ranks 95th and Laos ranks 95th of 191 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.